Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$242.49 - $301.46 $95,298 - $118,473
-393 Reduced 13.96%
2,422 $595,000
Q2 2022

Aug 04, 2022

SELL
$224.73 - $338.64 $43,597 - $65,696
-194 Reduced 6.45%
2,815 $697,000
Q1 2022

May 13, 2022

SELL
$277.25 - $366.29 $110,345 - $145,783
-398 Reduced 11.68%
3,009 $997,000
Q4 2021

Feb 11, 2022

BUY
$300.63 - $371.35 $601 - $742
2 Added 0.06%
3,407 $1.22 Million
Q3 2021

Nov 15, 2021

SELL
$310.19 - $376.2 $124,076 - $150,480
-400 Reduced 10.51%
3,405 $1.11 Million
Q2 2021

Aug 13, 2021

SELL
$262.71 - $351.17 $105,083 - $140,468
-400 Reduced 9.51%
3,805 $1.19 Million
Q1 2021

May 14, 2021

SELL
$285.92 - $355.13 $114,368 - $142,052
-400 Reduced 8.69%
4,205 $1.34 Million
Q4 2020

Feb 09, 2021

BUY
$251.88 - $324.2 $1,007 - $1,296
4 Added 0.09%
4,605 $1.49 Million
Q1 2020

May 14, 2020

BUY
$130.51 - $196.01 $1,827 - $2,744
14 Added 0.31%
4,601 $668,000
Q2 2019

Aug 13, 2019

SELL
$250.96 - $284.94 $2,258 - $2,564
-9 Reduced 0.2%
4,587 $1.2 Million
Q1 2019

May 14, 2019

BUY
$276.39 - $362.25 $2,487 - $3,260
9 Added 0.2%
4,596 $1.31 Million
Q3 2017

Oct 11, 2017

BUY
$145.39 - $168.6 $666,903 - $773,368
4,587
4,587 $773,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Plancorp, LLC Portfolio

Follow Plancorp, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plancorp, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plancorp, LLC with notifications on news.